FACT II Acquisition Aktie - FACT

Professionelle Tools für Privatanleger.

Premium

Current Price

9,97

Gebot

9,88

Fragen

10,04

Volumen

118

9,97 Tagesbereich 9,97

9,85 52-Wochen-Bereich 27,01

Handelsende

9,97

Handelsbeginn

9,97

Letzte Trade

9.95

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

49.403

Finanzvolumen

VWAP

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

PDL BioPharma Clarifies $13.00 Cost Basis in Facet Biotech Corporation

PDL BioPharma Clarifies $13.00 Cost Basis in Facet Biotech Corporation PR Newswire INCLINE VILLAGE, Nev., March 24 INCLINE VILLAGE, Nev., March...

Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Facet Biotech Corporation by Abbott Laboratories

Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of...

Kendall Law Group Investigates Facet Biotech Corporation Merger for Shareholders

Kendall Law Group, a national securities litigation firm is investigating Facet Biotech Corporation (NASDAQ: FACT) for...

dpa-AFX Überblick: UNTERNEHMEN vom 10.03.2010 - 15.30 Uhr

Aixtron will Umsatz und operativen Gewinn mehr als verdoppeln AACHEN - Der Anlagenbauer Aixtron <AIX.ETR> will im laufenden Jahr den...

Aktien New York Ausblick: Kaum verändert erwartet - Übernahme im Blick

NEW YORK (dpa-AFX) - Die New Yorker Aktienmärkte dürften am Mittwoch kaum verändert starten. Insgesamt rechnen Händler mit einem...

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Facet Biotech Corporation

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Facet...

Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Facet Biotech Corporation - FACT

Levi & Korsinsky is investigating the Board of Directors of Facet Biotech Corporation (“Facet Biotech” or the “Company”...

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

ABBOTT PARK, Ill. and REDWOOD CITY, Calif., March 9 /PRNewswire-FirstCall/ -- Abbott and Facet Biotech Corporation announced today a definitive...

Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors

SAN FRANCISCO, Jan. 11 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage cancer biotherapeutics company...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	9.97	10.0507	9.945	131656	9.954598	CS
4	0.06	0.605449041372	9.91	10.0507	9.91	51636	9.94911137	CS
12	-17.04	-63.0877452795	27.01	27.01	9.85	49403	9.91012994	CS
26	-17.04	-63.0877452795	27.01	27.01	9.85	21565	9.91012994	CS
52	-17.04	-63.0877452795	27.01	27.01	9.85	10869	9.91012994	CS
156	-17.04	-63.0877452795	27.01	27.01	9.85	3604	9.91012994	CS
260	-17.04	-63.0877452795	27.01	27.01	9.85	2481	9.91012994	CS

FACT - Frequently Asked Questions (FAQ)

What is the current FACT II Acquisition share price?

The current share price of FACT II Acquisition is US$ 9,97

What is the 1 year trading range for FACT II Acquisition share price?

FACT II Acquisition has traded in the range of US$ 9,85 to US$ 27,01 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
JTAIJet AI Inc	US$ 6,02 (133,33%)	104,48M
SRMSRM Entertainment Inc	US$ 0,6999 (95,50%)	254,39M
WRDWeRide Inc	US$ 31,4877 (83,39%)	21,07M
INLFINLIF Limited	US$ 16,27 (80,58%)	7,68M
MBRXMoleculin Biotech Inc	US$ 2,1201 (66,94%)	136,66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3,08 (-56,31%)	430,77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3,36 (-52,68%)	5,21k
CSAICloudastructure Inc	US$ 19,0001 (-49,58%)	1,03M
NEXNNexxen International Ltd	US$ 10,30 (-49,16%)	164,82k
BSLKBolt Projects Holdings Inc	US$ 0,6626 (-46,13%)	13,4M
CNSPCNS Pharmaceuticals Inc	US$ 0,1415 (31,26%)	480,49M
MGOLMGO Global Inc	US$ 0,7176 (-15,08%)	411,17M
SRMSRM Entertainment Inc	US$ 0,6999 (95,50%)	248,48M
INTCIntel Corporation	US$ 23,60 (-2,20%)	225,04M
NVDANVIDIA Corporation	US$ 138,85 (2,63%)	189,56M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

FACT II Acquisition Corporation (FACT)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

FACT Neueste Nachrichten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

PDL BioPharma Clarifies $13.00 Cost Basis in Facet Biotech Corporation

Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Facet Biotech Corporation by Abbott Laboratories

Kendall Law Group Investigates Facet Biotech Corporation Merger for Shareholders

dpa-AFX Überblick: UNTERNEHMEN vom 10.03.2010 - 15.30 Uhr

Aktien New York Ausblick: Kaum verändert erwartet - Übernahme im Blick

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Facet Biotech Corporation

Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Facet Biotech Corporation - FACT

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

FACT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

FACT II Acquisition Corporation (FACT) Börsenkurse

FACT II Acquisition Corporation (FACT)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

FACT Neueste Nachrichten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

PDL BioPharma Clarifies $13.00 Cost Basis in Facet Biotech Corporation

Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Facet Biotech Corporation by Abbott Laboratories

Kendall Law Group Investigates Facet Biotech Corporation Merger for Shareholders

dpa-AFX Überblick: UNTERNEHMEN vom 10.03.2010 - 15.30 Uhr

Aktien New York Ausblick: Kaum verändert erwartet - Übernahme im Blick

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Facet Biotech Corporation

Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Facet Biotech Corporation - FACT

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

FACT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen